aztreonam and mk-7655

aztreonam has been researched along with mk-7655 in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	3 (60.00)	2.80

Authors

Authors	Studies
Hsu, AJ; Tamma, PD	1
Brem, J; Hinchliffe, P; Lang, PA; Mulholland, AJ; Schofield, CJ; Spencer, J; Tooke, CL	1
Kasimati, A; Magkafouraki, E; Maraki, S; Mavromanolaki, VE; Moraitis, P; Scoulica, E; Stafylaki, D	1
Avison, MB; Dulyayangkul, P; Satapoomin, N	1
Biagi, M; Deshpande, LM; Lee, M; Mendes, RE; Patel, S; Shajee, A; Wenzler, E; Wu, T	1

Reviews

1 review(s) available for aztreonam and mk-7655

Article	Year
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms. Journal of the Pediatric Infectious Diseases Society, 2019, Jul-01, Volume: 8, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam	2019

Article

Year

Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms.

Journal of the Pediatric Infectious Diseases Society, 2019, Jul-01, Volume: 8, Issue:3

Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam

2019

Other Studies

4 other study(ies) available for aztreonam and mk-7655

Article	Year
Molecular Basis of Class A β-Lactamase Inhibition by Relebactam. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:10 Topics: Azabicyclo Compounds; Aztreonam; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Ceftazidime; Chromosomes, Bacterial; Clinical Trials, Phase III as Topic; Cloning, Molecular; Drug Combinations; Escherichia coli; Gene Expression; Genetic Vectors; Humans; Imipenem; Isoenzymes; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Molecular; Plasmids; Protein Binding; Protein Interaction Domains and Motifs; Recombinant Proteins; Stenotrophomonas maltophilia	2019
Ceftazidime-avibactam, meropenen-vaborbactam, and imipenem-relebactam in combination with aztreonam against multidrug-resistant, metallo-β-lactamase-producing Klebsiella pneumoniae. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:8 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Heterocyclic Compounds, 1-Ring; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests	2021
Klebsiella pneumoniae Mutants Resistant to Ceftazidime-Avibactam Plus Aztreonam, Imipenem-Relebactam, Meropenem-Vaborbactam, and Cefepime-Taniborbactam. Antimicrobial agents and chemotherapy, 2022, 04-19, Volume: 66, Issue:4 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Borinic Acids; Boronic Acids; Carboxylic Acids; Cefepime; Ceftazidime; Drug Combinations; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests	2022
Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales. Diagnostic microbiology and infectious disease, 2022, Volume: 103, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serine	2022